ERCC6L2 and acute myeloid leukemia: Furthermore, an ERCC6L2 variant, namely, c.1424del, was found to be enriched in the Finnish population, suggesting the existence of a founder effect, and was specifically associated with M6 AML, a particularly aggressive [20].